ABSTRACT
The discovery and validation of protein-protein interactions provides a knowledge base that is critical for defining protein networks and how they underpin the biology of the cell. Identification of protein interactions that are highly transient, or sensitive to biochemical disruption, can be very difficult. This challenge has been met by proximity labeling methods which generate reactive species that chemically modify neighboring proteins. The most widely used proximity labeling method is BioID, which features a mutant biotin ligase BirA(Arg118Gly), termed BirA*, fused to a protein of interest. Here, we explore how amino acid substitutions at Arg118 affect the biochemical properties of BirA. We found that relative to wild-type BirA, the Arg118Lys substitution both slightly reduced biotin affinity and increased the release of reactive biotinyl-5'-AMP. BioID using a BirA(Arg118Lys)-Lamin A fusion enabled identification of PCNA as a lamina-proximal protein in HEK293T cells, a finding that was validated by immunofluorescence microscopy. Our data expand on the concept that proximity labeling by BirA fused to proteins of interest can be modulated by amino acid substitutions that affect biotin affinity and the release of biotinyl-5'-AMP.
Subject(s)
Biotin/chemistry , Biotinylation/methods , Carbon-Nitrogen Ligases/chemistry , Escherichia coli Proteins/chemistry , Repressor Proteins/chemistry , Biotin/genetics , Carbon-Nitrogen Ligases/genetics , Escherichia coli/enzymology , Escherichia coli Proteins/genetics , HEK293 Cells , Humans , Protein Interaction Maps/genetics , Repressor Proteins/geneticsABSTRACT
Nuclear receptors (NRs) comprise a superfamily of ligand-regulated transcription factors implicated in a host of physiological processes, including development, differentiation, and proliferation. Translated in the cytoplasm, NRs must undergo import into the nucleus in order to modulate transcription of target genes in response to cognate hormones. NRs also undergo export from the nucleus, and there is emerging evidence that NR nucleocytoplasmic shuttling contributes to their regulation. Nucleocytoplasmic shuttling may provide a nexus for crosstalk between NRs and kinase pathways. Here we review some of the key studies on nuclear import and export of steroid hormone receptors within the NR superfamily, address some of the challenges in experimental dissection of NR transport and discuss recent findings linking specific kinase pathways to NR export.
Subject(s)
Cell Nucleus/metabolism , Receptors, Steroid/metabolism , Active Transport, Cell Nucleus/genetics , Active Transport, Cell Nucleus/physiology , Amino Acid Sequence , Animals , Molecular Sequence Data , Receptors, Steroid/chemistryABSTRACT
The androgen receptor (AR) has critical functions as a transcription factor in both normal and cancer cells, but the specific mechanisms that regulate its nuclear localization are not well defined. We found that an AR mutation commonly reported in prostate cancer generates an androgen-independent gain of function for nuclear import. The substitution, Thr877Ala, is within the ligand-binding domain, but the nuclear import gain of function is mediated by the bipartite nuclear localization signal (NLS) spanning the DNA-binding domain (DBD) and hinge region. Bipartite NLS activity depends on the structure provided by the DBD, and protein interactions with the bipartite NLS are repressed by the hinge region. The bipartite NLS is recognized by importin 7, a nuclear import receptor for several proteins. Importin 7 binding to AR, however, inhibits import by shielding the bipartite NLS. Androgen binding relieves the inhibition by inducing a switch that promotes exchange of importin 7 for karyopherin alpha import receptors. Importin 7 contributes to the regulation of AR import by restraining import until androgen is detected in the cytoplasm.
Subject(s)
Amino Acid Substitution , Androgens/physiology , Cell Nucleus/metabolism , Karyopherins/metabolism , Receptors, Androgen/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Active Transport, Cell Nucleus , Amino Acid Motifs , Animals , COS Cells , Chlorocebus aethiops , Cytoplasm/metabolism , HeLa Cells , Humans , Male , Metribolone/pharmacology , Models, Molecular , Nuclear Localization Signals/genetics , Prostatic Neoplasms , Protein Binding , Receptors, Androgen/chemistry , Receptors, Androgen/genetics , Reticulocytes/metabolism , Testosterone Congeners/pharmacologyABSTRACT
The androgen receptor undergoes nuclear import in response to ligand, but the mechanism by which it undergoes nuclear export is poorly understood. We developed a permeabilized cell assay to characterize nuclear export of the androgen receptor in LNCaP prostate cancer cells. We found that nuclear export of endogenous androgen receptor can be stimulated by short double-stranded DNA oligonucleotides. This androgen receptor export pathway is dependent on ATP hydrolysis and is enhanced by phosphatase inhibition with okadaic acid. Fluorescence recovery after photobleaching in permeabilized cells, under the conditions that stimulate androgen receptor export, suggested that double-stranded DNA-dependent export does not simply reflect the relief of a nuclear retention mechanism. A radiolabeled androgen was used to show that the androgen receptor remains ligand-bound during translocation through the nuclear pore complex. A specific inhibitor to the DNA-dependent protein kinase, NU7026, inhibits androgen receptor export and phosphorylation. In living cells, NU7026 treatment increases androgen-dependent transcription from endogenous genes that are regulated by androgen receptor. We suggest that DNA-dependent protein kinase phosphorylation of the androgen receptor, or an interacting component, helps target the androgen receptor for export from the nucleus.